4//SEC Filing
Weiser Jorg 4
Accession 0001209191-21-020207
CIK 0001490978other
Filed
Mar 11, 7:00 PM ET
Accepted
Mar 12, 4:52 PM ET
Size
21.4 KB
Accession
0001209191-21-020207
Insider Transaction Report
Form 4
Weiser Jorg
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2021-03-11$4.34/sh+3,924$17,030→ 171,140 total - Sale
Common Stock
2021-03-11$82.00/sh−3,800$311,600→ 163,416 total - Exercise/Conversion
Stock Option (right to buy)
2021-03-11−3,924→ 16,141 totalExercise: $4.34Exp: 2028-11-29→ Common Stock (3,924 underlying) - Exercise/Conversion
Common Stock
2021-03-11$3.07/sh+8,659$26,583→ 175,875 total - Sale
Common Stock
2021-03-11$82.00/sh−8,659$710,038→ 167,216 total - Sale
Common Stock
2021-03-11$82.00/sh−3,924$321,768→ 167,216 total - Exercise/Conversion
Stock Option (right to buy)
2021-03-11−8,659→ 18,095 totalExercise: $3.07Exp: 2026-05-10→ Common Stock (8,659 underlying)
Holdings
- 17,390(indirect: BY ANTERIO CONSULT AND RESEARCH GMBH)
Common Stock
Footnotes (4)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2020.
- [F2]The shares are beneficially owned by Anterio Consult & Research GmbH ("Anterio"). Dr. Weiser is a shareholder and former managing director of Anterio and disclaims beneficial ownership of the shares held by Anterio, except to the extent of his pecuniary interest therein, if any.
- [F3]The option was granted on May 11, 2016 and is fully vested.
- [F4]This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.
Issuer
Schrodinger, Inc.
CIK 0001490978
Entity typeother
Related Parties
1- filerCIK 0001797782
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 7:00 PM ET
- Accepted
- Mar 12, 4:52 PM ET
- Size
- 21.4 KB